Next Article in Journal
Daily Variation in the Feeding Activity of Pacific Crown-of-Thorns Starfish (Acanthaster cf. solaris)
Previous Article in Journal
Effects of Forest Environments in Attenuating D-Galactose-Induced Immunosenescence: Insights from a Murine Model
Previous Article in Special Issue
Meliponini Geopropolis Extracts Induce ROS Production and Death in Leishmania amazonensis Promastigotes and Axenic Amastigotes In Vitro
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Leishmania in Texas: A Contemporary One Health Scoping Review of Vectors, Reservoirs, and Human Health

1
National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA
2
William T. Shearer Center for Human Immunobiology, Texas Children’s Hospital, Houston, TX 77030, USA
3
Department of Kinesiology, Rice University, Houston, TX 77251, USA
4
Texas Department of State Health Services, Region 6/5 South, Houston, TX 77023, USA
5
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
6
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
*
Author to whom correspondence should be addressed.
Biology 2025, 14(8), 999; https://doi.org/10.3390/biology14080999 (registering DOI)
Submission received: 6 July 2025 / Revised: 23 July 2025 / Accepted: 29 July 2025 / Published: 5 August 2025

Simple Summary

Leishmaniasis is a parasitic disease spread by sand flies that affects millions of people worldwide. Although it is typically found in tropical areas, cases are now being identified in the United States, particularly in Texas. In this region, the species Leishmania mexicana (which causes skin sores) is present. Most infections appear to be locally acquired, meaning that people become infected without traveling out of the state. This review brings together existing research on leishmaniasis in Texas, examining how the disease spreads, which animals may harbor the parasite, and the influence of the environment. We found that rising temperatures, expanding cities, and habitat changes may be contributing to the movement of the disease into new areas. These findings demonstrate the need for stronger disease tracking and increased awareness among healthcare providers to improve early diagnosis and treatment. A better understanding of how leishmaniasis is spreading in Texas will support efforts to protect communities and guide public health efforts.

Abstract

Leishmaniasis, a vector-borne neglected tropical disease, affects over 6.2 million people globally. Case acquisition is increasingly recognized in the United States, and in Texas, most reported cases are locally acquired and speciated to Leishmania mexicana. We conducted a scoping literature review to systematically assess contemporary research on Leishmania in humans, animals, reservoir hosts, or vectors in Texas after 2000. Out of 22 eligible studies, the most prevalent themes were case reports, followed by studies on domestic animals, reservoirs, and vectors, with several studies bridging multiple disciplines. Climate change, urbanization, and habitat encroachment appear to be driving the northward expansion of L. mexicana, which is primarily attributed to shifts in the habitats of key vectors (Lutzomyia anthophora) and reservoirs (Neotoma spp.). Leishmania appears to be expanding into new areas, with potential for further spread. As ecological conditions evolve, strengthening surveillance and clinician awareness is crucial to understanding disease risk and improving early detection and treatment in affected communities.

1. Introduction

Leishmaniasis is a neglected tropical disease that disproportionately affects underserved and resource-limited communities worldwide [1]. It is caused by protozoan parasites of the Leishmania genus, which are transmitted primarily through the bites of infected female phlebotomine sand flies. The disease causes significant global health burdens, affecting over 6.2 million people, with an estimated 1.1 million new cases annually [2,3]. Among the three primary clinical forms of leishmaniasis—cutaneous, mucocutaneous, and visceral—cutaneous leishmaniasis (CL) is the most commonly reported, responsible for nearly 400,000 disability-adjusted life years (DALYs) [3].
While CL is traditionally associated with tropical and subtropical regions of South America, Central America, and parts of Mexico, domestically acquired cases are increasingly recognized in the United States. Autochthonous transmission has been documented in multiple states, with Texas emerging as a key region for understanding the dynamics of domestic transmission. Cases were first documented in Texas in 1903, and most reported CL cases in Texas have been locally acquired [4], highlighting the need for enhanced surveillance and targeted public health interventions.
Previous literature reviews on leishmaniasis have primarily focused on the epidemiology and transmission dynamics of Leishmania in highly endemic regions, such as South America and the Middle East [4]. The number of reviews assessing human case distribution, vector ecology, and environmental drivers of transmission within Texas and the United States remains limited. This information is essential for strengthening vector surveillance, improving case detection, and informing public health strategies.
To address this gap, we conducted a scoping literature review to systematically assess existing research on leishmaniasis in Texas and identify knowledge gaps. Specifically, we examine human cases, vector ecology, reservoir hosts, and environmental drivers influencing transmission in Texas. Using a “One Health” approach, we provide a holistic perspective on Leishmania in Texas to inform research needs, enhance surveillance efforts, and support disease mitigation strategies.

2. Materials and Methods

We followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis Protocols Extension for Scoping Reviews (PRISMA-ScR) (Supplementary File S1).

2.1. Study Identification

We searched OVID Medline and PubMed for articles published between 2000 and 2024 using (“Leishmania” OR “leishmaniasis”) AND (“Texas” OR “TX”), applied as keywords, titles, abstracts, and Medical Subject Headings (MeSH) terms. This time frame was deliberately chosen to reflect contemporary (rather than historical) epidemiological patterns in Texas. We included studies published in English after 2000 that contained primary research examining Leishmania in humans, domestic or wild animals, reservoir hosts, or vectors within the state of Texas. Papers were excluded if they focused solely on laboratory experiments or were conference abstracts without full-text availability. The most recent search was performed in January 2024, and the complete search strategy is provided in Supplementary File S2. To capture the relevant gray literature, we searched ProQuest for theses and dissertations.

2.2. Study Screening

All search results were exported into reference management software (Zotero version 6.0.36), in which the duplicates were removed. Two reviewers screened all publications’ titles, abstracts, and full texts based on the eligibility criteria. Discrepancies were resolved through discussion and consultation with a third reviewer if needed. Additionally, we screened references of included studies to identify additional relevant literature.

2.3. Data Extraction and Synthesis

A structured data-charting form was developed to extract key variables, including article details (authors, journal, and publication year) and study characteristics (study location, objectives, methodology, sample size, and outcomes). Three reviewers collaboratively charted the data, discussed the results, and continuously updated the data-charting form in an iterative process.

2.4. Data Summarization and Presentation

Studies were categorized based on their outcomes, and included human cases, domestic animal infections, reservoir hosts, and/or vector surveillance. Summary statistics were used to describe the distribution of the literature across study themes, designs, and locations. The study selection process is shown in Figure 1.

3. Results

3.1. Study Selection

After the full-text screening, 22 articles (17 peer-reviewed and 5 gray literature reports) met the eligibility criteria and were included in this review. Table 1 summarizes the geographic focus, study period, study design, outcomes, primary findings, and classification (human, reservoir, domestic animal, and/or vector) of the included studies. The most prevalent themes were human disease (n = 7, 32%), followed by domestic animals (n = 4, 18%), reservoirs (n = 3, 14%), and vector studies (n = 3, 14%). Several studies have bridged disciplines, including some combination of human disease, domestic animal disease, vector, and reservoir studies (n = 5, 23%).
The studies used various methods and are broadly categorized into clinical studies or case reports (n = 7, 32%), epidemiological studies (n = 2, 9%), molecular diagnostics (n = 2, 9%), and ecological investigations (n = 11, 50%). Clinical studies included case reports, retrospective reviews, and evaluations based on patient presentation, biopsies, and histopathology. Epidemiological studies were primarily cross-sectional or retrospective case reviews, often incorporating assessments of travel history. Molecular approaches commonly included PCR and sequencing to detect and characterize Leishmania species. Ecological studies focused on cross-sectional or longitudinal sand fly and rodent trapping, species composition analysis, ecological niche modeling, and susceptibility testing. Several studies integrated multiple approaches to provide a more comprehensive understanding of transmission dynamics. There was a notable lack of research on prevention or treatment.

3.2. Human Cases, Clinical Features, Diagnosis, and Treatment

3.2.1. Human Cases

Human leishmaniasis cases were first documented in Texas in 1903 near the southeastern border with Mexico [13,26]. By the mid-1940s, cases had been reported in south-central Texas, reaching central Texas by the early 1980s and spreading further north by the 1990s [10,13]. Recognizing its growing presence, Texas became the only U.S. state to designate leishmaniasis as a reportable condition in 2007, requiring healthcare providers to report suspected and confirmed cases to the Texas Department of State Health Services (DSHS) [20].
Over the past 25 years, autochthonous CL has been increasingly documented, with its range now extending from Texas into southeastern Oklahoma [20]. However, leishmaniasis in Texas is likely underreported, as the literature documents the discovery of previously unreported cases [4,24]. For example, a recent study of CL in Texas reported 69 human cases of CL since 2007, only 14 of which were reported to DSHS [4]. Despite increasing numbers of case reports, the actual burden of leishmaniasis is unclear, due to the lack of prevalence data in Texas.
In Texas, Leishmania mexicana is the predominant species identified in humans, animals, and vectors [5]. Multiple studies have conducted molecular characterization of L. mexicana isolates collected from human cases in Texas, detecting specific single-nucleotide polymorphisms (SNPs) in the RNA-Internal Transcribed Spacer-2 (ITS-2) gene [24]. Unique polymorphisms at ITS-2 C647 and C649 have been identified in Texas isolates, and non-travel-associated L. mexicana infections in Texas predominantly belong to genotype CCC [24,25]. Additional polymorphisms in genes such as mannose phosphate isomerase (MPI), malate dehydrogenase (MDH), and 6-phosphogluconate dehydrogenase (6PGD) have been described [24]. Additionally, interestingly, despite characterizing a limited number of isolates and genes, Nepal et al. observed genetic variations among strains, suggesting that L. mexicana strains in Texas may be experiencing evolutionary selection pressure leading to novel synonymous and nonsynonymous mutations [24]. Regardless, Texas-specific polymorphisms indicate ongoing enzootic disease transmission in Texas and potentially unique transmission dynamics. Further studies are needed to determine whether these polymorphisms influence clinical presentation, disease severity, and/or treatment response.

3.2.2. Clinical Features

Since 2000, 58 unique cases of autochthonous cutaneous leishmaniasis (CL) have been reported in the literature in Texas residents (Table 2). The year of diagnosis was provided for 94.8% (55/58) of cases, and ranged from 2005 to 2019. Notably, the first half of this period (2005-2011) resulted in only 17 cases, whereas 38 cases were diagnosed between 2012 and 2019, suggesting an increasing incidence or awareness of autochthonous CL in Texas. In the 29.3% of cases with a reported age, the median age of autochthonous CL cases was 64 (range: 6 months - 82 years). With thirteen adult and four pediatric cases, there was an apparent skew towards older populations. This may reflect age-related healthcare-seeking behaviors, especially as CL lesions can mimic dermatologic neoplasms [19,21].
Autochthonous cases of CL spanned 23 Texas counties, with the most common counties being Collin (6), Dallas (6), Grayson (6), and Denton (5) (Table 2). Most commonly, lesions were found on the face and neck (n = 26) or upper extremity (n = 24). However, three cases included multiple lesions that spanned various anatomic locations. Most cases initially presented to primary care physicians or dermatologists, while one presented to an ophthalmologist as the lesion was located on the eyelid [14].

3.2.3. Diagnosis and Treatment

The duration between lesion appearance and appropriate diagnosis was reported in 16 cases, with a median time to diagnosis of 4 months. All diagnoses were made using histopathology; however, initial punch biopsies were inconclusive in two cases [6,19]. This necessitated further excisions, which yielded the correct diagnosis of CL. Further speciation was performed in 43.1% of the evaluated cases, and L. mexicana was identified.
Since L. mexicana typically causes non-disseminating cutaneous disease, the Infectious Diseases Society of America and the American Society of Tropical Medicine and Hygiene advise that immunocompetent hosts do not require treatment [27]. However, treatment can be provided for cosmetic reasons, as non-treatment may be associated with superinfection or more pronounced scarring [27]. In the U.S., such treatments may include amphotericin B, antimonials, miltefosine, “azole” antifungal compounds, paromomycin, heat therapy, and cryotherapy [27]. In the nine cases that included information regarding clinical courses and treatments, a combination of pharmacologic and non-pharmacologic regimens was applied, including various treatment combinations. Overall, these patients were treated with amphotericin B, fluconazole, miltefosine, ketoconazole, paromomycin, heat therapy, cryotherapy, and/or lesion excision.
In addition to recommended anti-leishmanial management, six individuals received antibiotic treatment [10,14,19,24]. Four of these individuals were given antibiotics empirically before the diagnosis of CL was made [10,14,24], while one individual tested positive for Proteus mirabilis and Klebsiella oxytoca on cultures collected during the diagnostic biopsy [19]. In one case reported by Wright et al., gentamicin was used; however, it is unclear whether it was administered empirically prior to diagnosis [10]. Empiric treatment with corticosteroids was also observed in five cases. In Maloney et al., the initial punch biopsy showed findings that suggested nonspecific chronic inflammation, warranting treatment with topical steroids [6]. However, in the remaining four cases, corticosteroids were prescribed empirically (before the diagnosis was made) and reportedly worsened lesions in three cases [10,20].
Together, these cases suggest that autochthonous CL is a growing zoonotic threat to human health in Texas, where the incidence of reported autochthonous disease appears to have increased by 124%, based on a comparison of the period from 2012 to 2019 with the period from 2005 to 2011. As the U.S. historically has been declared non-endemic for leishmaniasis, increasing physician awareness of the potential for autochthonous CL in individuals with no significant travel history is crucial. Due to the observed skew of autochthonous CL reported in older individuals and the reported cases in which CL lesions have been misdiagnosed as dermatologic neoplasms, providers in diverse specialties, including primary care, family medicine, and dermatology, must consider CL in their differentials. This is likely to improve patient outcomes by reducing the time to diagnosis, the incidence of misdiagnoses, and the use of empiric antibiotics and corticosteroids that may ultimately exacerbate CL lesions.

3.3. Sand Flies

Several studies have identified Lutzomyia species as potential vectors of Leishmania spp. in Texas. While approximately 70 distinct sand fly species worldwide have been identified as competent vectors for Leishmania, Lutzomyia anthophora is the only species definitively identified as a vector for L. mexicana transmission in Texas (Figure 1) [5,23,28]. This was reported by Kipp et al., who detected human blood in Lu. anthophora for the first time [20]. Although other sand fly species, including Lu. aquilonia, Lu. diabolica, Lu. shannoni, Lu. texana, and Lu. vexator have been collected in Texas; none have demonstrated a natural infection with L. mexicana [4,5,11,14,15,20,23]. Therefore, the ecology and vectorial competency of additional Lutzomyia species previously found in Texas require further investigation [11].

3.3.1. Sand Fly Biology and Behavior

Lu. anthophora is active February–November, with periods of peak abundance and activity occurring in intervals of two months [5,29]. This species undergoes 3–5 generations annually, with synchronous egg hatching within 24 h [5]. Activity declines when mean monthly low temperatures fall below 10 °C, with most activity ending by September, although some collections have been reported as late as November [5]. Increased sand fly abundance has been associated with increased ambient air temperature and the temperature of woodrat nests [15], indicating that they may survive in these warmer environments during the winter. Year-round activity may be possible in southern Texas due to its warmer climate [15]. Data on the daily activity patterns of sand flies is limited, as traps are rarely set for an entire 24-h period. However, studies indicate peak activity at dusk, overnight, and dawn [11,14,15,23,24].

3.3.2. Sand Fly Ecology and Distribution

Sand fly abundance and distribution in Texas appear to be shaped by ecological factors such as temperature, moisture, vegetation, and host availability. However, most existing studies rely on convenience sampling rather than systematic sampling, which limits our understanding of broader patterns. High sand fly abundance has been documented in shrubland, wetland, and forest habitats, and tends to correlate with domestic animal activity [23] and proximity to water [15]. Sand flies have also been collected in grasslands and woodland/scrub ecosystems [11]. Suburban and rural development encroaching on undeveloped lands may increase the risk for human exposure due to proximity to wildlife reservoirs such as burrowing woodrats, opossums, armadillos, and cotton rats [10]. Some evidence suggests that environmental modifications such as brush clearing and reducing outdoor lighting may help suppress local sand fly populations [23]. Although female sand flies primarily feed on rodents and other mammals, they may opportunistically bite humans and domestic animals, especially when preferred hosts are scarce [14]. Furthermore, their dispersal range and the effective range of light traps remain poorly understood. However, existing research suggests they are weak fliers and that transmission is typically localized around host habitats [5].

3.4. Roles of Wildlife and Domestic Animals

3.4.1. Wildlife Reservoirs

Rodents, particularly woodrats (Neotoma floridana and Neotoma micropus), appear to be the primary reservoirs of Leishmania in Texas (Figure 1) [9]. N. micropus is abundant in the brushlands of southern Texas, with ecological ranges extending into New Mexico, Colorado, and portions of Kansas and Oklahoma [7]. Notably, infections in N. micropus have been reported to persist for an average of 190 days [9]. Interestingly, a case in Brenham, Texas, reported in 2002, was outside N. micropus’s range, suggesting an alternative reservoir in East Texas [6]. This is further supported by the discovery of an infected N. floridana 80 km away in a similar ecological region [9]. Leishmania has been detected in Peromyscus attwateri [18], while studies from northeastern Mexico implicate deer mice (Peromyscus) and hispid cotton rats (Sigmodon) [30]. Significantly, many of these ecological niches extend into the southern U.S., suggesting a broader geographic risk [4,7,13]. This emerging data suggests that additional rodent species may contribute to transmission (Figure 2), but further investigation is required.

3.4.2. Domestic Animals

Stray canines and felines infected with L. mexicana have been documented across northern, central, and western Texas [12,17,18,23], with a notable study detecting Leishmania DNA in 41 stray dogs (26%) in El Paso County [17]. A study of stray cats in El Paso revealed that 19 (12%) tested positive for L. mexicana [16]. Infections in stray cats and dogs provide evidence of L. mexicana enzootic transmission in Texas, though studies suggest that they are incidental hosts rather than true reservoirs [17,18]. However, dogs and cats may act as “bridge reservoirs,” facilitating the movement of Leishmania from sylvatic to peridomestic settings (Figure 2) [22,31]. Therefore, further investigation is needed to understand their roles as potential reservoirs and any impact on human transmission.

3.5. Trends and Patterns

Recent studies suggest that climate change, urbanization, and habitat encroachment reshape the distribution of Leishmania vectors and reservoirs in Texas (Figure 3) [4,13,17,32]. The northward expansion of L. mexicana is primarily attributed to shifts in the habitats of key vectors (Lu. anthophora) and reservoirs (N. micropus and N. floridana) [10,12,16]. For example, shifts in N. micropus’ range to northern, wooded environments and changes in sand fly habitats may contribute to the northern spread of L. mexicana [10,12]. Other potential hosts, such as opossums, armadillos, and cotton rats, may facilitate transmission by sustaining necessary vector–host relationships.
Agricultural changes, including the spread of rodent crop pests (e.g., Sigmodon sp.), may also influence the distribution of L. mexicana [30]. However, some argue that urban expansion, habitat encroachment, and increased disease awareness may explain the rise in reported leishmaniasis cases, as opposed to an explanation based on actual geographic spread [10,19,20]. Regardless, climate models predict that the risk of Leishmania exposure could extend to southeastern Canada by 2050, underscoring the urgency of understanding how climate and human-modified environments may influence disease dynamics [4].

4. Discussion

The emergence and geographic expansion of Leishmania mexicana in Texas and the southern U.S. is a significant yet underrecognized public health concern. Once considered only travel-associated, cutaneous leishmaniasis is increasingly reported among individuals in the U.S. with no travel history [4]. These reports highlight the need to reframe cutaneous leishmaniasis as a locally acquired zoonosis in Texas and other U.S. regions in which autochthonous cases have been seen.
The presence of Leishmania in Texas reflects a complex ecology involving sylvatic vectors, rodent reservoirs, and environmental conditions conducive to transmission. Lu. anthophora is believed to be the primary vector, while woodrats and other rodents may sustain sylvatic enzootic cycles [5,9,23,28]. However, increasing human encroachment, land-use changes, and environmental stressors such as drought may facilitate spillover into peri-domestic and suburban settings by bringing humans and domestic animals closer to infected vectors and reservoirs [14]. Even in areas without rapid urbanization, stable environments with certain features, such as woodrat habitats and domestic fowl, may support persistent enzootic transmission [14]. Historical case reports illustrate how poor waste management, such as debris piles, abandoned vehicles, and nearby animal hosts, can sustain sand fly populations [14].
Despite its growing relevance, leishmaniasis remains poorly recognized in clinical settings within the United States. Physicians are responsible for identifying, diagnosing, and treating L. mexicana while correctly reporting it to public health authorities [4]. However, leishmaniasis is often viewed as an “exotic” or exclusively travel-associated disease, leading to low levels of physician awareness and frequent misdiagnosis in clinical settings [19,33]. Underreporting remains a significant challenge, especially outside Texas, where no public health reporting requirement exists. Enhanced surveillance systems for vectors, reservoirs, and human cases, improved diagnostic tools, and increased education for healthcare providers are essential to enhance disease monitoring and improve patient outcomes. Treatment for L. mexicana is often not indicated for immunocompetent adults with a single, small lesion, particularly if it is not in a cosmetically sensitive area. Nevertheless, most providers in the previously reported cases have often treated children and adults with a variety of methods, often because the case specifics varied from the above criteria. Some of these treatments have the potential for significant side effects, and there is also concern that Leishmania may develop resistance over time [34,35]. Of note, long-term CL sequelae include scarring, which may be decreased with treatment but is not eliminated. Since scarring—especially in more visible areas such as the face—can have significant impacts on individual mental health and social stigma, additional research on scar-mitigating treatment modalities on active and healed CL lesions would significantly benefit human health.

4.1. Research Gaps

Multiple knowledge gaps exist in our understanding of L. mexicana in Texas and the United States. First, the role of domestic animals in the L. mexicana transmission cycle is poorly understood. Whether stray canine and feline infections are incidental hosts or potential reservoirs contributing to sustained transmission is unclear [17,18]. Second, studies are needed to systematically map the parasite’s geographic range in Texas and evaluate the risk of human infection [20]. The northward expansion of reservoir and vector ranges, which is especially due to climate change, suggests that endemic Leishmania transmission may extend farther into the United States [13]. Ongoing surveillance is also needed to track potential northward expansion [10]. Genomic surveillance offers a promising avenue to detect strain-specific SNPs that may indicate ongoing transmission cycles in Texas that are distinct from those in Mexico and Central and South America. To assess genetic and immunological factors, comparisons of L. mexicana strains could determine how genetic variations influence clinical presentation, disease progression, and treatment response [20,24]. There is also a need to clarify the roles of lesser-known vectors, such as other Lutzomyia species and non-woodrat rodents like Peromyscus attwateri, in maintaining enzootic transmission [11,18]. Addressing these research gaps will provide a clearer understanding of the epidemiology of L. mexicana and guide strategies to mitigate its impact on human and animal health.

4.2. Vector Control Strategies

Leishmaniasis prevention continues to rely heavily on vector control, including environmental management and insecticide use [32]. Primary insecticide methods include indoor residual spraying, insecticide-treated nets, repellants, and impregnated dog collars. However, overreliance on these tools can lead to insecticide resistance [36]. Local and state vector control programs are not equipped to conduct sand fly surveillance or test sand fly populations for Leishmania spp. Encouragingly, surveillance could be adapted into existing vector control programs, as sand flies can be found in bycatch during mosquito trapping. In addition, oral insecticides from the isoxazoline class (e.g., fluralaner, sold as Bravecto®) have demonstrated efficiency against specific sand fly species [37,38,39]. Further research is needed to determine whether these effects extend to the sand fly species found in Texas. This approach could represent a valuable One Health intervention if domestic dogs and cars serve as bridge reservoirs.

4.3. Implications for Policy and Practice

Several changes are needed to better prevent and control leishmaniasis in the United States. Adding leishmaniasis to the list of nationally notifiable conditions would enable a more consistent surveillance and detection of outbreaks. In addition, improved diagnostic tools and provider education are essential to reduce misdiagnosis and enhance case detection. Early disease recognition is important given that L. mexicana infection can cause prominent scarring and even mucosal or visceral leishmaniasis in immunocompromised patients [27,40]. Lastly, public health authorities should encourage diagnosis and reporting of cases and integrate One Health approaches into prevention efforts. These steps will help clarify the disease burden and guide evidence-based responses.

4.4. Strengths and Limitations

The primary strength of this review lies in its comprehensive identification of the English-language literature related to leishmaniasis in Texas, including gray literature reports. We used an extensive and systematic search strategy with collaboration from a multidisciplinary team. This approach allowed us to assess studies on vectors, reservoirs, and domestic animals and provide a holistic One Health perspective on the disease in Texas. However, we acknowledge that our study has several limitations. We excluded studies published before 2000 in order to focus on the current ecological context, which may have excluded some relevant contemporary data. We also limited the inclusion criteria to articles explicitly discussing leishmaniasis in Texas, though this could have excluded broader studies with relevant implications. In addition, we developed the study classifications after reading the full texts, which could have introduced bias; however, we believed this was necessary for a comprehensive assessment. Finally, we excluded travel-acquired cases, though some could have been misclassified, with infections potentially occurring before departure or after return to Texas.

5. Conclusions

Leishmaniasis was first identified in southern Texas in 1903 and has since expanded into Oklahoma. The actual disease burden is likely underestimated due to underdiagnosis and underreporting. Although ecological data and surveillance are limited, current evidence suggests an increasing disease burden and continued geographic spread. Contributing factors include human encroachment into endemic areas and climate change, which may alter the distribution of vectors and reservoirs.
Effectively addressing Leishmania in Texas will require a One Health approach integrating human, animal, and environmental health perspectives. Furthermore, strengthening surveillance infrastructure and increasing clinician awareness are crucial for informing public health efforts and understanding the disease risk in our communities. Ultimately, reframing L. mexicana as a locally relevant zoonosis and responding with multidisciplinary One Health strategies will improve recognition, guide prevention and control strategies, and reduce the disease burden in affected communities.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/biology14080999/s1, File S1: PRISMA ScR Checklist [41]; File S2: PubMed Search Strategy.

Author Contributions

Conceptualization, M.H.J. and S.M.G.; literature search, M.H.J. and R.C.; data compilation and analysis, M.H.J., R.C., N.L.T. and S.G.; writing—original draft preparation, M.H.J., R.C., N.L.T., S.G. and S.M.G.; writing—review and editing, all authors. All authors have read and agreed to the published version of the manuscript.

Funding

Dawn M. Wetzel was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI146349, a Welch Grant for Chemistry (I-2086), and funds from the University of Texas Southwestern Medical Center Department of Pediatrics. The funders did not play a role in the writing of the manuscript. The content is solely the authors’ responsibility and does not necessarily represent the official views of the National Institutes of Health.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Data sharing is not applicable to this article, as no datasets were generated or analyzed during the current study. Figures were created in BioRender.com.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ruiz-Postigo, J.A.; Jain, S.; Madjou, S.; Maia-Elkhoury, A.N.; Valadas, S.; Warusavithana, S.; Osman, M.; Yajima, A.; Lin, Z.; Beshah, A. Global Leishmaniasis Surveillance, 2022: Assessing Trends over the Past 10 Years; WHO: Geneva, Switzerland, 2023. [Google Scholar]
  2. Alvar, J.; Vélez, I.D.; Bern, C.; Herrero, M.; Desjeux, P.; Cano, J.; Jannin, J.; den Boer, M.; WHO Leishmaniasis Control Team. Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE 2012, 7, e35671. [Google Scholar] [CrossRef]
  3. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021; Global Burden of Disease Collaborative Network: Washington, DC, USA, 2024. [Google Scholar]
  4. McIlwee, B.E.; Weis, S.E.; Hosler, G.A. Incidence of Endemic Human Cutaneous Leishmaniasis in the United States. JAMA Dermatol. 2018, 154, 1032–1039. [Google Scholar] [CrossRef]
  5. McHugh, C.P.; Ostrander, B.F.; Raymond, R.W.; Kerr, S.F. Population Dynamics of Sand Flies (Diptera: Psychodidae) at Two Foci of Leishmaniasis in Texas. J. Med. Entomol. 2001, 38, 268–277. [Google Scholar] [CrossRef]
  6. Maloney, D.M.; Maloney, J.E.; Dotson, D.; Popov, V.L.; Sanchez, R.L. Cutaneous Leishmaniasis: Texas Case Diagnosed by Electron Microscopy. J. Am. Acad. Dermatol. 2002, 47, 614–616. [Google Scholar] [CrossRef]
  7. Merkelz, R.; Kerr, S.F. Demographics, Den Use, Movements, and Absence of Leishmania mexicana in Southern Plains Woodrats (Neotoma Micropus). Southwest. Nat. 2002, 47, 70. [Google Scholar] [CrossRef]
  8. Raymond, R.W.; McHugh, C.P.; Witt, L.R.; Kerr, S.F. Temporal sand Spatial Distribution of Leishmania mexicana Infections in a Population of Neotoma micropus. Mem. Inst. Oswaldo Cruz. 2003, 98, 171–180. [Google Scholar] [CrossRef]
  9. McHugh, C.P.; Thies, M.L.; Melby, P.C.; Yantis, L.D.; Raymond, R.W.; Villegas, M.D.; Kerr, S.F. Short Report: A Disseminated Infection of Leishmania mexicana in an Eastern Woodrat, Neotoma Floridana, Collected in Texas. Am. J. Trop. Med. Hyg. 2003, 69, 470–472. [Google Scholar] [CrossRef]
  10. Wright, N.A.; Davis, L.E.; Aftergut, K.S.; Parrish, C.A.; Cockerell, C.J. Cutaneous Leishmaniasis in Texas: A Northern Spread of Endemic Areas. J. Am. Acad. Dermatol. 2008, 58, 650–652. [Google Scholar] [CrossRef] [PubMed]
  11. Claborn, D.M.; Rowton, E.D.; Lawyer, P.G.; Brown, G.C.; Keep, L.W. Species Diversity and Relative Abundance of Phlebotomine Sand Flies (Diptera: Psychodidae) on Three Army Installations in the Southern United States and Susceptibility of a Domestic Sand Fly to Infection with Old World Leishmania major. Mil. Med. 2009, 174, 1203–1208. [Google Scholar] [CrossRef] [PubMed]
  12. Trainor, K.E.; Porter, B.F.; Logan, K.S.; Hoffman, R.J.; Snowden, K.F. Eight Cases of Feline Cutaneous Leishmaniasis in Texas. Vet. Pathol. 2010, 47, 1076–1081. [Google Scholar] [CrossRef] [PubMed]
  13. Gonzalez, C.; Wang, O.; Strutz, S.E.; Gonzalez-Salazar, C.; Sanchez-Cordero, V.; Sarkar, S. Climate Change and Risk of Leishmaniasis in North America: Predictions from Ecological Niche Models of Vector and Reservoir Species. PLoS Negl. Trop. Dis. 2010, 4, e585. [Google Scholar] [CrossRef]
  14. Clarke, C.F.; Bradley, K.K.; Wright, J.H.; Glowicz, J. Case Report: Emergence of Autochthonous Cutaneous Leishmaniasis in Northeastern Texas and Southeastern Oklahoma. Am. J. Trop. Med. Hyg. 2013, 88, 157–161. [Google Scholar] [CrossRef]
  15. Alshhrany, M. Investigation of the Environmental Factors Associated with the Temporal Abundance of Lutzomyia anthophora on a Ranch Near Poth, Texas; University of the Incarnate Word: San Antonio, TX, USA, 2016. [Google Scholar]
  16. Gonzalez, P. Identification of Leishmania spp. and T. cruzi Parasites in Stray Felines in El Paso, Texas Through Polymerase Chain Reaction. Master’s Thesis, University of Texas at El Paso, El Paso, TX, USA, 2015. [Google Scholar]
  17. Kipp, E. Detecting Enzootic Leishmaniasis and American Trypanosomiasis in Stray Dogs in El Paso County, Texas and the Potential for Autochthonous Transmission to Humans. Master’s Thesis, University of Texas at El Paso, El Paso, TX, USA, 2015. [Google Scholar]
  18. Kipp, E.J.; Mariscal, J.; Armijos, R.X.; Weigel, M.; Waldrup, K. Genetic Evidence of Enzootic Leishmaniasis in a Stray Canine and Texas Mouse from Sites in West and Central Texas. Mem. Inst. Oswaldo Cruz 2016, 111, 652–654. [Google Scholar] [CrossRef] [PubMed]
  19. Oetken, T.; Hiscox, B.; Orengo, I.; Rosen, T. Cutaneous Leishmaniasis Mimicking Squamous Cell Carcinoma. Dermatol. Online J. 2017, 23, 13030/qt8f36814f. [Google Scholar] [CrossRef]
  20. Kipp, E.J.; de Almeida, M.; Marcet, P.L.; Bradbury, R.S.; Benedict, T.K.; Lin, W.; Dotson, E.M.; Hergert, M. An Atypical Case of Autochthonous Cutaneous Leishmaniasis Associated with Naturally Infected Phlebotomine Sand Flies in Texas, United States. Am. J. Trop. Med. Hyg. 2020, 103, 1496–1501. [Google Scholar] [CrossRef]
  21. Nguyen, D.A.; Charles, J.E.M.; Worrell, J.T.; Wilkes, D.V. Cutaneous Leishmaniasis in a 65-Year-Old North Texas Male, Treated with Cryotherapy: A Case Report. SAGE Open Med. Case Rep. 2020, 8, 2050313X20904593. [Google Scholar] [CrossRef]
  22. Meyers, A.C.; Auckland, L.; Meyers, H.F.; Rodriguez, C.A.; Kontowicz, E.; Petersen, C.A.; Travi, B.L.; Sanders, J.P.; Hamer, S.A. Epidemiology of Vector-Borne Pathogens Among U.S. Government Working Dogs. Vector Borne Zoonotic Dis. Larchmt. N 2021, 21, 358–368. [Google Scholar] [CrossRef]
  23. Hopke, K.; Meyers, A.; Auckland, L.; Hamer, S.; Florin, D.; Diesel, A.; Patterson, A. Leishmania mexicana in a Central Texas Cat: Clinical Presentation, Molecular Identification, Sandfly Vector Collection and Novel Management. JFMS Open Rep. 2021, 7, 2055116921999595. [Google Scholar] [CrossRef]
  24. Nepal, B.; McCormick-Baw, C.; Patel, K.; Firmani, S.; Wetzel, D.M. Cutaneous Leishmania mexicana Infections in the United States: Defining Strains through Endemic Human Pediatric Cases in Northern Texas. mSphere 2024, 9, e0081423. [Google Scholar] [CrossRef]
  25. de Almeida, M.; Cama, V.; Kamb, M. Is Cutaneous Leishmaniasis Autochthonous in the United States? In Proceedings of the American Society for Tropical Medicine and Hygiene, Chicago, IL, USA, 13–17 November 2024. [Google Scholar]
  26. McHugh, C.P.; Melby, P.C.; LaFon, S.G. Leishmaniasis in Texas: Epidemiology and Clinical Aspects of Human Cases. Am. J. Trop. Med. Hyg. 1996, 55, 547–555. [Google Scholar] [CrossRef]
  27. Aronson, N.; Herwaldt, B.L.; Libman, M.; Pearson, R.; Lopez-Velez, R.; Weina, P.; Carvalho, E.; Ephros, M.; Jeronimo, S.; Magill, A. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am. Soc. Trop. Med. Hyg. 2017, 96, 24–45. [Google Scholar] [CrossRef]
  28. Boelaert, M.; Sundar, S. Leishmaniasis. In Manson’s Tropical Diseases, 23rd ed.; Farrar, J., Hotez, P.J., Junghanss, T., Kang, G., Lalloo, D., White, N., Eds.; Elsevier Inc.: Philadelphia, PA, USA, 2014; pp. 631–651. ISBN 978-0-7020-5101-2. [Google Scholar]
  29. Endris, R.G.; Young, D.G.; Butler, J.F. The Laboratory Biology of the Sand Fly Lutzomyia anthophora (Diptera: Psychodidae). J. Med. Entomol. 1984, 21, 656–664. [Google Scholar] [CrossRef]
  30. Rodríguez-Rojas, J.J.; Rodríguez-Moreno, Á.; Berzunza-Cruz, M.; Gutiérrez-Granados, G.; Becker, I.; Sánchez-Cordero, V.; Stephens, C.R.; Fernández-Salas, I.; Rebollar-Téllez, E.A. Ecology of Phlebotomine Sandflies and Putative Reservoir Hosts of Leishmaniasis in a Border Area in Northeastern Mexico: Implications for the Risk of Transmission of Leishmania mexicana in Mexico and the USA. Parasite Paris Fr. 2017, 24, 33. [Google Scholar] [CrossRef]
  31. Esteve-Gassent, M.D.; Perez de Leon, A.A.; Romero-Salas, D.; Feria-Arroyo, T.P.; Patino, R.; Castro-Arellano, I.; Gordillo-Perez, G.; Auclair, A.; Goolsby, J.; Rodriguez-Vivas, R.I.; et al. Pathogenic Landscape of Transboundary Zoonotic Diseases in the Mexico-US Border Along the Rio Grande. Front. Public Health 2014, 2, 177. [Google Scholar] [CrossRef]
  32. Zhu, C.S. What’s Eating You? Phlebotomine Sandflies and Leishmania Parasites. Cutis 2023, 112, E16–E19. [Google Scholar] [CrossRef] [PubMed]
  33. Ekemen, S.; Nalcaci, M.; Toz, S.; Sanjoba, C.; Demirkesen, C.; Cetin, E.D.; Tecimer, T.; Yildiz, P.; Gursel, M.; Ince, U.; et al. Diagnostic Challenges in Cutaneous Leishmaniasis Due to Atypical Leishmania infantum: Pathologists’ Insights from Re-Emergence Zones. Front. Med. 2024, 11, 1453211. [Google Scholar] [CrossRef]
  34. Oliveira, L.F.; Schubach, A.O.; Martins, M.M.; Passos, S.L.; Oliveira, R.V.; Marzochi, M.C.; Andrade, C.A. Systematic Review of the Adverse Effects of Cutaneous Leishmaniasis Treatment in the New World. Acta Trop. 2011, 118, 87–96. [Google Scholar] [CrossRef] [PubMed]
  35. Wijnant, G.-J.; Dumetz, F.; Dirkx, L.; Bulté, D.; Cuypers, B.; Van Bocxlaer, K.; Hendrickx, S. Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Front. Trop. Dis. 2022, 3, 837460. [Google Scholar] [CrossRef]
  36. Balaska, S.; Fotakis, E.A.; Chaskopoulou, A.; Vontas, J. Chemical Control and Insecticide Resistance Status of Sand Fly Vectors Worldwide. PLoS Negl. Trop. Dis. 2021, 15, e0009586. [Google Scholar] [CrossRef]
  37. Gomez, S.A.; Lucientes, J.; Castillo, J.A.; Peris, M.P.; Delacour, S.; Ortega, P.; Oropeza, R.-V.; Picado, A. A Randomized, Blinded, Controlled Trial to Assess Sand Fly Mortality of Fluralaner Administered Orally in Dogs. Parasit. Vectors 2018, 11, 627. [Google Scholar] [CrossRef]
  38. Queiroga, T.B.D.; Ferreira, H.R.P.; dos Santos, W.V.; de Assis, A.B.L.; de Araújo Neto, V.T.; da Câmara, A.C.J.; Fagundes Neto, J.C.; dos Reis, R.K.; Nascimento, M.S.L.; Gama, R.A.; et al. Fluralaner (Bravecto®) Induces Long-Term Mortality of Lutzomyia longipalpis after a Blood Meal in Treated Dogs. Parasit. Vectors 2020, 13, 609. [Google Scholar] [CrossRef] [PubMed]
  39. Gomez, S.A.; Curdi, J.L.; Hernandez, J.A.C.; Peris, P.P.; Gil, A.E.; Velasquez, R.V.O.; Hernandez, P.O.; Picado, A. Phlebotomine Mortality Effect of Systemic Insecticides Administered to Dogs. Parasit. Vectors 2018, 11, 230. [Google Scholar] [CrossRef] [PubMed]
  40. Mitchell, K.L.; Smithhart, M.C.; Covington, B.R.; Byrd, T.M.; Sullivan, S.J.; Dixon, M.K. Visceral Leishmaniasis (Kala-Azar) Caused by L. mexicana in a Patient with AIDS. Proc (Bayl Univ Med Cent) 2022, 36, 70–72. [Google Scholar] [CrossRef] [PubMed]
  41. Tricco, A.C.; Lillie, E.; Zarin, W.; O’Brien, K.K; Colquhoun, H.; Levac, D.; Moher, D.; Peters, M.D.J.; Horsley, T.; Weeks, L.; et al. Visceral Leishmaniasis (Kala-Azar) Caused by L. mexicana in a Patient with AIDS. Proc (Bayl Univ Med Cent) 2022, 36, 70–72. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Study selection process using PRISMA-ScR guidelines. Flow diagram showing the identification, screening, eligibility assessment, and inclusion of studies in the scoping review of Leishmania in Texas.
Figure 1. Study selection process using PRISMA-ScR guidelines. Flow diagram showing the identification, screening, eligibility assessment, and inclusion of studies in the scoping review of Leishmania in Texas.
Biology 14 00999 g001
Figure 2. The proposed lifecycle for Leishmania in Texas.
Figure 2. The proposed lifecycle for Leishmania in Texas.
Biology 14 00999 g002
Figure 3. Potential factors contributing to changes in Leishmania endemicity in Texas.
Figure 3. Potential factors contributing to changes in Leishmania endemicity in Texas.
Biology 14 00999 g003
Table 1. Characteristics of included manuscripts.
Table 1. Characteristics of included manuscripts.
First Author (Year)Main ObjectiveStudy PeriodGeographic FocusMethods and Outcome MeasuresMain FindingsCategory for This ReviewReference
McHugh (2001)To describe sand fly abundance and biology at two human leishmaniasis foci1997–1999Medina County, Texas;
Lackland Air Force Base, Bexar County, Texas
Longitudinal sand fly collection, species composition, and abundance analysisLutzomyia anthophora was the predominant species. Lutozymia diabolica and Lutozymia texana were also collected. One blood-fed Lu. anthophora was Leishmania-positive.Vector[5]
Maloney (2002)To present a locally acquired CL case diagnosed by electron microscopyUnknownBrenham, Washington County, TexasCase report;
used electron microscopy to identify Leishmania spp. in tissue samples
Confirmed CL diagnosis in a Texas patientClinical – case report[6]
Merkelz (2002)To study the population dynamics of the Southern Plains woodrat (Neotoma micropus) and assess the prevalence of L. mexicana1997–1998La Copita Research Area, Jim Wells County, TexasLongitudinal trap, release, and recapture; quarterly
PCR on ear punch biopsies
No Leishmania-positive woodrats. Year-round breeding observed.Reservoir[7]
Raymond (2003)To determine spatial and seasonal variations in Leishmania prevalence in Southern Plains woodrats (N. micropus)1998–2000Lackland Air Force Base, Bexar County, TexasLongitudinal trapping, PCR on ear biopsiesA 14.7% prevalence of L. mexicana.
Of the incident cases for which a transmission period could be estimated, most appeared to have acquired their infections during the year’s cooler months. Mean persistence of 191 days.
Reservoir[8]
McHugh (2003)To report disseminated L. mexicana infection in an eastern woodrat (Neotoma floridana)Jan 2001Bedias, Grimes County, TexasCross-sectional;
Biopsy, PCR, clinical presentation
L. mexicana was detected in both ears and all feet, demonstrating disseminated cutaneous infection. Oral and nasal mucosa were negative.Reservoir—case report[9]
Wright (2008)To report the first autochthonous CL cases in North Texas2005–2007Dallas–-Fort Worth, TexasCross-sectional
Histological examination
Nine cases, all Caucasian, even sex distribution. No travel reported.Clinical—case reports[10]
Claborn (2009)To conduct surveillance of sand fly populations and their susceptibility to Old World Leishmania sp.Late spring and summer 2006–2007Fort Hood, Bell County, Texas;
Fort Bragg, North Carolina;
Fort Campbell, Kentucky
Longitudinal
Sand fly collection, species diversity, and susceptibility testing
Identified five sand fly species (Lutozymia shannoni, Lutozymia aquilonia, Lutozymia vexator, Lu. diabolica, and Lu. anthophora).
Lu. shannoni was susceptible to Leishmania major.
Vector[11]
Trainor (2010)To report autochthonous L. mexicana infections in eight domestic cats2004–2008Bastrop, Bell, Burleson, Caldwell, Hood, Kaufman, Lampasas, Tarrant Counties, TexasCross-sectional
Skin biopsy, histological examination, and PCR
Amastigotes visualized. In total, 5/8 cats PCR-positive for L. mexicana/Leishmania amazonensis.Domestic animal[12]
Gonzalez (2010)To assess potential climate change impacts on sand fly vectors (Lu. anthophora and Lu. diabolica) and reservoir species (N. albigula, N. micropus, N. floridana, N. mexicana)Post–1990United States, Mexico, and CanadaEcological niche model using Maxent (presence/absence)There is a north–south band of habitat that is, at best, marginally suitable for any of the four Neotoma species models. This may explain the temporal pattern of the spread of Leishmania cases in Texas. The pre-2000 records of leishmaniasis from Texas fall within the area predicted to be a suitable habitat for Neotoma micropus. Identified potential shifts in N. floridana and Lu. diabolica in eastern North America and N. micropus and Lu. anthophora further west.Modeling; Reservoir; Vector[13]
Clarke (2013)To report three autochthonous CL cases and the collection of rodents and sand flies near two case-patients2003–2006Lamar County, Texas;
Collin County, Texas;
McCurtain County, Oklahoma (n = 2)
Cross-sectional
Case reports, sand fly and rodent trapping
One case was rural, and one case was an urban-rural interface.
No Leishmania-positive woodrats.
Two species of sand flies were identified (Lu. anthophora and Lu. vexator).
Clinical—case reports; Reservoir; Vector[14]
Alshhrany (2016)To investigate seasonal sand fly abundance and related environmental factors2014–2015Poth, Texas;
Wilson County, Texas
Longitudinal
Sand fly collection, woodrat nest, and ambient temperature recording.
Identified two sand fly species (Lu. anthophora, Lu. texana).
Correlation between sand flies and maximum ambient/nest temperatures, but not minimum ambient temperature.
Vector[15]
Gonzalez (2015)To determine the Leishmania spp. prevalence among stray cats collected in El Paso County, Texas2014–2015El Paso County, TexasCross-sectional
Visualized for skin lesions and organ discoloration, biopsy, and PCR
In total, 12% of stray cats were infected with Leishmania mexicana. All cases occurred in July–December 2014.
Of positives, 47% lacked skin lesions and organ discoloration.
Domestic animal[16]
Kipp (2015)To determine the Leishmania spp. prevalence among stray dogs collected in El Paso County, Texas2014–2015El Paso County, TexasCross-sectional
Visualized for skin lesions and organ discoloration, biopsy, and PCR
In total, 26% of stray dogs tested positive for Leishmania mexicana. 71% of positive samples lacked visible skin lesions.Domestic animal[17]
Kipp (2016)To screen stray dogs and sylvatic mammals for Leishmania spp.2011–2012El Paso County, Texas
Mason County, Texas
Cross-sectional
Visually examined for the presence of skin lesions; skin biopsy, and PCR
One L. mexicana-positive stray dog from a peri-urban, agricultural area adjacent to El Paso.
One mouse, Peromyscus attwateri, was positive for L. mexicana.
Stray dog infection is likely incidental.
Reservoir; Domestic animal[18]
Oetken (2017)To report an autochthonous CL case misdiagnosed as squamous cell cancer2014Cuero, Texas;
DeWitt County, Texas
Cross-sectional
Clinical presentation and histology
PCR-confirmed L. mexicana.Clinical—case report[19]
McIlwee (2018)To assess the endemicity of human leishmaniasis in the United States using a multicenter observational study2007–2017Various counties throughout northern and central TexasRetrospective case review of diagnosed leishmaniasis cases
Determined travel history for the last 10 years
All autochthonous cases were from Texas. Of these, only 20% were reported to the Texas Department of State Health Services (DSHS). A total of 32% were speciated by PCR as L. mexicana.Clinical—epidemiology[4]
Kipp (2020)To report an atypical, autochthonous CL case and sand fly collection near the case-patient’s residence2016Caldwell County, TexasPunch biopsy, histopathology, sand fly collectionL. mexicana genotype C647/C640 identified.
Six blood-fed Lu. anthophora contained human DNA. Of female sand flies, 3% were positive, and 1 had an identical sequence to the clinical case.
Clinical—case report; Vector[20]
Nguyen (2020)To describe an autochthonous CL case in North TexasUnknownPresented in North TexasSkin biopsy, histopathologyBar-shaped kinetoplast visualized. Received a curative single session of cryotherapy.Clinical—case report[21]
Meyers (2021)To determine the prevalence of infection and exposure to vector-borne pathogens among working dogs2015–2018“Texas, where sand fly vectors occur”Tested using Kalazar Detect Rapid Test Canine and PCRA total of 4% of dogs were positive on the Kalazar Detect Rapid Test Canine, with two considered to have primary T. cruzi. None were positive by PCR.Domestic animal[22]
Hopke (2021)To describe feline CL/mucocutaneous and report sand fly surveillance at the residenceUnknownBryan, TexasBiopsy, PCR;
Sand fly collection
L. mexicana was identified in both cutaneous and nasal mucosa samples. Identified Lu. shannoni (2) and Lu. anthophora (1) sand flies, all negative for Leishmania.Domestic animal; Vector[23]
Nepal (2024)To report three CL cases in pediatric patients in northern Texas and propose a method for strain-typing US-endemic L. mexicana2018–2019Ellison County, Texas;
Grayson County, Texas
Biopsy, multilocus sequence analysis (MLSA) for SNP analysis.PCR confirmed L. mexicana infection. Clinical isolates exhibited genetic polymorphisms previously documented in Texan strains of L. mexicana.Clinical—case reports; Clinical—diagnostics[24]
de Almeida (2024)To assess the prevalence of CL among travel- and non-travel-associated cases2005–2019United StatesDNA sequencing of the ITS2 locus, genotyping of SNPsIn total, 90% of samples with the L. mexicana genotype CCC were from non-travelers identified in TexasClinical—epidemiology; Clinical—diagnostics[25]
Abbreviations: CL = Cutaneous Leishmaniasis
Table 2. Clinical features of reported human cutaneous leishmaniasis cases in Texas.
Table 2. Clinical features of reported human cutaneous leishmaniasis cases in Texas.
Article ReportingAge (Years)SexTexas County of OriginEthnicityAnatomic Location of Lesion (Specific)Anatomic Location of Lesion (General)Year of Histologic DiagnosisDuration Before Diagnosis (Months)Treatment *Travel History (Last 5 Years)Infective SpeciesOutcomeReference
Wright et al., 200870MDallasCR armupper extremity20053Amphotericin, fluconazoleNone outside the county of residenceNRNR[10]
Clarke et al., 201374FLamarNRL eyelidface/neck20051.5Heat therapyNRNRNR[14]
Wright et al., 200860FCollinCNoseface/neck20061.5Ketoconazole, cryotherapyNone outside the county of residenceNRNR[10]
Clarke et al., 2013 *8FCollinCFace, L upper armmultiple20065Amphotericin B, fluconazoleNone outside the county of residenceL. mexicanaNR[14]
Wright et al., 200876FCollinCL foreheadface/neck20064CryotherapyNone outside the county of residenceNRNR[10]
Wright et al., 200864MDentonCR abdomentrunk20063NoneNone outside the county of residenceNRNR[10]
Wright et al., 200880MHillCL armupper extremity200624NoneNone outside the county of residenceNRNR[10]
McIlwee et al., 2018NRMWiseNRR abdomentrunk2006NRNRNRNRNR[4]
Wright et al., 200857MEllisCL backtrunk20072Fluconazole, surgical excisionNRNRNR[10]
Wright et al., 200864FEllisCR upper aspect of the chesttrunk20071Local excision, heat therapyNRNRNR[10]
McIlwee et al., 2018NRFGraysonCForearm, wristupper extremity2007NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFHillCUpper armupper extremity2007NRNRNRL. mexicanaNR[4]
Wright et al., 200882FTarrantCL cheekface/neck20073FluconazoleNRNRNR[4]
McIlwee et al., 2018NRFTravisNRChin, neckface/neck2007NRNRNRNRNR[4]
McIlwee et al., 2018NRMParkerNRL wristupper extremity2010NRNRNRNRNR[4]
McIlwee et al., 2018NRFDallasCFace, L elbow, buttockmultiple2011NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFRockwallCUpper armupper extremity2011NRNRNRNRNR[4]
McIlwee et al., 2018NRMRockwallCFaceface/neck2012NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFBrazosNRForeheadface/neck2013NRNRNRNRNR[4]
McIlwee et al., 2018NRFBurlesonCUpper shoulderupper extremity2013NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRMCollinNRL armupper extremity2013NRNRNRNRNR[4]
McIlwee et al., 2018NRFDallasNRR foreheadface/neck2013NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFDallasCShoulderupper extremity2013NRNRNRNRNR[4]
McIlwee et al., 2018NRFDentonCUpper armupper extremity2013NRNRNRNRNR[4]
McIlwee et al., 2018NRMDentonCForearmupper extremity2013NRNRNRNRNR[4]
McIlwee et al., 2018NRFFayetteCL eyelidface/neck2013NRNRNRNRNR[4]
McIlwee et al., 2018NRFGraysonNRR lower eyelidface/neck2013NRNRNRNRNR[4]
McIlwee et al., 2018NRFHuntCR wristupper extremity2013NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFTravisCUpper armupper extremity2013NRNRNone outside the U.S.L. mexicanaNR[4]
McIlwee et al., 2018NRMBexarNRUpper eyelidface/neck2014NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFCaldwellCFaceface/neck2014NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFCaldwellNRL cheekface/neck2014NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFGraysonCFace, eyelidface/neck2014NRNRNRNRNR[4]
McIlwee et al., 2018NRFGraysonNRR foreheadface/neck2014NRNRNRNRNR[4]
McIlwee et al., 2018NRFGraysonNRL upper armupper extremity2014NRNRNRNRNR[4]
McIlwee et al., 2018NRFMadisonCL templeface/neck2014NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRMTarrantCR earface/neck2014NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRMWiseCForearm, a large portion of the armupper extremity2014NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFBurlesonNRL earlobeface/neck2015NRNRNRNRNR[4]
McIlwee et al., 2018NRFCollinCFaceface/neck2015NRNRNRLeishmania speciesNR[4]
McIlwee et al., 2018NRMCollinCEar, backmultiple2015NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRMDallasCL forearmupper extremity2015NRNRNRNRNR[4]
McIlwee et al., 2018NRFDentonCForearmupper extremity2015NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRMDeWittCFace, cheekface/neck2015NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFRockwallNRL upper armupper extremity2015NRNRNRNRNR[4]
McIlwee et al., 2018NRMTravisCElbowsupper extremity2015NRNRNRLeishmania speciesNR[4]
McIlwee et al., 2018NRFWashingtonNRR dorsal handupper extremity2015NRNRNRNRNR[4]
McIlwee et al., 2018NRFAustinNRR anterior upper neckface/neck2016NRNRNRNRNR[4]
Kipp et al., 202067MCaldwellCR leglower extremity20166Fluconazole, miltefosine, ketoconazoleNone outside TexasL. mexicanaTreatment refractory 26 months later[20]
McIlwee et al., 2018NRFDallasNRR faceface/neck2016NRNRNRNRNR[4]
McIlwee et al., 2018NRMDentonNRR upper armupper extremity2016NRNRNRL. mexicanaNR[4]
McIlwee et al., 2018NRFPalo PintoNRL foreheadface/neck2016NRNRNRL. mexicanaNR[4]
Nepal et al., 20242FEllisHispanicR inferior jawface/neck2018-20196FluconazoleNone outside North TexasL. mexicanaResolved[24]
Nepal et al., 20243MEllisHispanicL armupper extremity2018-20195FluconazoleNoneL. mexicanaResolved[24]
Nepal et al., 20240.5MGraysonCR templeface/neck2018-20194Fluconazole, paromomycinNone outside the U.S.L. mexicanaResolved[24]
Oetken et al.41MDeWittNRL cheekface/neckNR4NoneNone to “endemic” areasL. mexicanaResolved[19]
Maloney et al., 200278FWashingtonNRR forearmupper extremityNR8NoneNone outside TexasPresumed L. mexicanaImproving without treatment[6]
Nguyen et al65MNRNRL shoulderupper extremityNRmultipleCryotherapyNone outside TexasNRResolved[21]
Abbreviations: F = Female; M = Male; NR = Not Reported; C = Caucasian; L = Left; R = Right; U.S. = United States. * Treatments do not include empirical treatments that were given before the diagnosis was made.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jibowu, M.H.; Chung, R.; Tang, N.L.; Guo, S.; Lawton, L.-A.; Sullivan, B.J.; Wetzel, D.M.; Gunter, S.M. Leishmania in Texas: A Contemporary One Health Scoping Review of Vectors, Reservoirs, and Human Health. Biology 2025, 14, 999. https://doi.org/10.3390/biology14080999

AMA Style

Jibowu MH, Chung R, Tang NL, Guo S, Lawton L-A, Sullivan BJ, Wetzel DM, Gunter SM. Leishmania in Texas: A Contemporary One Health Scoping Review of Vectors, Reservoirs, and Human Health. Biology. 2025; 14(8):999. https://doi.org/10.3390/biology14080999

Chicago/Turabian Style

Jibowu, Morgan H., Richard Chung, Nina L. Tang, Sarah Guo, Leigh-Anne Lawton, Brendan J. Sullivan, Dawn M. Wetzel, and Sarah M. Gunter. 2025. "Leishmania in Texas: A Contemporary One Health Scoping Review of Vectors, Reservoirs, and Human Health" Biology 14, no. 8: 999. https://doi.org/10.3390/biology14080999

APA Style

Jibowu, M. H., Chung, R., Tang, N. L., Guo, S., Lawton, L.-A., Sullivan, B. J., Wetzel, D. M., & Gunter, S. M. (2025). Leishmania in Texas: A Contemporary One Health Scoping Review of Vectors, Reservoirs, and Human Health. Biology, 14(8), 999. https://doi.org/10.3390/biology14080999

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop